Subject
Pharmacology,General Medicine
Reference46 articles.
1. Pathogenesis of nonalcoholic steatohepatitis: an overview;Parthasarathy;Hepatol. Commun.,2020
2. Non-Alcoholic Steatohepatitis (NASH) - a review of a crowded clinical landscape, driven by a complex disease;Fraile;Drug Des., Dev. Ther.,2021
3. Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial;Alkhouri;J. Hepatol.,2022
4. A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial;Pedrosa;Contemp. Clin. Trials,2020
5. GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity;Overton;Br. J. Pharmacol.,2008
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献